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General anesthesiaAbstract Objectives: To compare the effect of remifentanil vs dexmedetomidine on hemodynamic
response of noxious stimuli and neonatal outcome in preeclamptic parturient underwent C.S. under
G.A.
Methods: This blinded, prospective, randomized trial included 50 preeclamptic parturients under-
went C.S under G.A., randomized into two equal groups [25 patients each]: group R [remifentanil]:
received 1 lg/kg loading and 0.05 lg/kg/min infusion doses and group D [dexmedetomidine]
received 1/kg loading and 0.2 lg/kg/h infusion doses. Maternal MAP and HR were assessed before
medication (T0), just after induction of GA (TI), just after intubation (TT), two minutes after intu-
bation (TT2), just after skin incision (TS), two minutes after skin incision (TS2), just after delivery of
the baby (TD), and at the end of operation (TE). Time between induction and fetal delivery (I-D
interval), time between incision of the uterus and delivery (U-D interval), and time between stop
of the infusion of the tested drugs and delivery (D-D interval) were recorded. Neonatal Apgar score
was recorded at 1 and 5 min and the need for resuscitative measures.
Results: Maternal MAP and HR in group R were statistically lower at (TI), (TT), (TT2), (TS) and
(TS2).Neonatal Apgar score was statistically lower in group R with higher incidence for tactile stim-
ulation.
Conclusion: Both remifentanil and dexmedetomidine were effective on blunting the pressor
response to noxious stimuli in severely preeclamptic parturients. While remifentanil was marginally
more effective in suppressing the pressor response, dexmedetomidine was safer for the neonates.
 2016 Publishing services by Elsevier B.V. on behalf of Egyptian Society of Anesthesiologists. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
General anesthesia (GA) is typically used for Cesarean Sec-
tion (CS) when neuraxial anesthesia is contraindicated: such
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infection, and patient refusal, or for emergency situations.
Endotracheal intubation usually increases arterial blood pres-
sure (ABP) and heart rate (HR) [1]. With preeclampsia, this
pressor response to intubation is exaggerated [2]. This abrupt
increase in ABP can cause cerebral edema, intracranial hemor-
rhage [3], cardiac failure, and pulmonary edema, with
increased rate of morbidity and mortality in both the mother
and fetus [4]. In addition, this pressor response raises maternal
plasma catecholamine levels, that can induce utero-placental
vasoconstriction and placental insufficiency [5,6]. Therefore,
close control of pressor responses during intubation and surgi-
cal stimulation can protect both the mother and the fetus in
preeclamptic parturients. Opioids are commonly used to atten-
uate this pressor response. However, because of its adverse
neonatal effects, opioids are classically avoided at induction
of GA for CS.
Remifentanil was a potent opioid with rapid onset (maxi-
mum effect at 1–3 min) [7] and ultra-short duration of action,
with a consistent half-time of 3–5 min, regardless of the dura-
tion of the infusion [8]. It is an attractive option when GA is
required for CS. It has been proved to blunt the pressor
response to intubation in healthy [9,10] and severely
preeclamptic [11,12] parturients, but the concern of neonatal
respiratory depression still exists [13]. The success to blunt
the pressor response was defined as a systolic blood pressure
(SBP) did not exceed 160 mmHg, a critical point for the risk
of intracranial hemorrhage to occur in preeclamptic parturi-
ents [14].
Dexmedetomidine, a highly selective a-2 adrenergic agonist,
can induce sedation, analgesia, and amnesia without respira-
tory depression [15,16]. Preoperative administration of
dexmedetomidine, either as a single dose (0.5–1 lg/kg)
[17,18] or as continuous infusion (0.6 lg/kg/h) [19], showed
to effectively blunt hemodynamic and hormonal responses to
tracheal intubation [20], reduce anesthetic requirements [21],
and enhance postoperative analgesia [22]. Several studies suc-
cessfully used dexmedetomidine for labor analgesia or CS
under GA, or to improve the quality of pain relief with
opioid-based analgesia [23,24]. Other studies employed
dexmedetomidine in the healthy [25] and the preeclamptic
[26,27] parturients for control of maternal hemodynamics.
Later on, a study carried out on 2015, compared the efficacy
of remifentanil on hemodynamics, depth of anesthesia, anes-
thetic consumption and neonatal outcome with that of
dexmedetomidine in non-preeclamptic parturients [28]. How-
ever, to our knowledge, no study compared the efficacy of
these drugs with severe preeclampsia.
In our study, we aimed to compare the efficacy of remifen-
tanil (1 lg/kg iv bolus followed by 0.05 lg/kg/min continuous
infusion), with dexmedetomidine (1 lg/kg iv bolus followed by
0.2 lg/kg/min continuous infusion), for attenuation of the
pressor response to endotracheal intubation and surgical stim-
ulation, in severely preeclamptic parturient candidate for CS
under GA, and to evaluate the neonatal outcome in both stud-
ied groups.
2. Materials and methods
Following approval of our institutional ethical committee and
obtaining written informed consents, 50 parturients scheduledfor elective CS under GA, of ASA grade I or II, 20–40 years
old, presented with severe preeclampsia [29,30] were recruited
in this blinded, prospective, and randomized, trial. This study
was blinded to the data-collecting investigator and the studied
drugs were prepared and administered by other investigators
blind to the data collected.
GA was required when regional anesthesia was contraindi-
cated or failed, or with patient refusal to regional anesthesia.
This study was performed in the Kasr Al-Ainy University
Hospitals over a period of six months started from March
2015.
Exclusion criteria included emergency cases, evidence of
fetal compromise or intrauterine growth retardation, HELLP
syndrome (hemolysis, elevated liver enzymes, and low platelet
levels), morbid obesity, diabetes mellitus, or known allergies
to the tested drugs. Parturients with history of cardiac, pul-
monary, hepatic, renal or other diseases were also excluded.
Preoperative monitoring of fetal heart sounds was applied to
exclude fetal distress. Preoperatively, all patients were assessed
clinically and investigated for the exclusion criteria. Complete
blood count, bleeding profile, liver and kidney function tests
were routinely recorded for all patients.
All patients were randomly allocated into two groups,
Group R (remifentanil) and Group D (dexmedetomidine), using
a computer generated randomization list and a sealed envelope
technique (n= 25/group). An intravenous line was established
and infusion of lactated Ringer’s solution was started at a rate
of 15 ml/kg/h till delivery. All patients received a loading dose
of iv magnesium sulfate (4 gm), followed by 1 gm/h iv infusion
for seizure prophylaxis, and iv hydralazine (5 mg) at 20 min
intervals when SBP > 160 mmHg or diastolic arterial pressure
(DBP) >110 mmHg. All patients were fasted for six hours and
pre-medicated with 30 ml of oral sodium citrate and iv rani-
tidine 150 mg and ondansetron 4 mg. Patients were placed in
the supine position with left lateral tilt and preoxygenated with
100% O2 face mask over three minutes. ECG, pulse oximetry,
capnography and train-of-four monitoring were applied. A left
radial artery catheter was inserted under local anesthesia for
invasive continuous blood pressure measurement.
In group (R), a bolus of intravenous (iv) remifentanil (1 lg/
kg) was given over 30–60 sec, followed by a continuous infu-
sion of (0.05 lg/kg/min), while in group (D), a bolus of iv
dexmedetomidine (1 lg/kg) was given over 10 min, followed
by a continuous infusion of (0.2 lg/kg/h). In both groups,
the infusion was stopped with peritoneal incision.
Anesthesia was then induced in both groups with iv bolus of
propofol (2 mg/kg) followed by a continuous infusion of 6–
10 mg/kg/h, succinylcholine (1.5 mg/kg) was given, cricoid
pressure was applied, the trachea was intubated and the
patient was ventilated with a mixture of oxygen in air (50%).
Atracurium 0.5 mg/kg was given after succinylcholine effect
faded. After delivery, fentanyl 3 lg/kg and oxytocin (30 IU)
in 500 ml Ringer’s solution were given. When skin suturing
started, propofol infusion was stopped, atropine 0.02 mg/kg
and neostigmine 0.05 mg/kg were used for reversal of neuro-
muscular block under train-of-four monitoring, and the
patient was extubated when she was able to localize. Extuba-
tion time (from cessation of propofol infusion to extubation)
was recorded.
Mean arterial blood pressure (MAP) and heart rate (HR)
were recorded five minutes after radial arterial puncture (T0),
just after induction of GA (TI), just after intubation (TT),
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two minutes after skin incision (TS2), just after delivery of the
baby (TD), and at the end of operation (TE).
Time between induction and fetal delivery (I-D interval),
time between incision of the uterus and delivery (U-D interval),
time between stop of the infusion of the tested drugs and deliv-
ery (D-D interval), and average dose of propofol required to
maintain anesthesia were recorded.
Basic neonate examination was performed, Apgar score was
recorded at 1 and 5 min, and the need for tactile stimulation,
bag-mask ventilation, endotracheal intubation, or mechanical
ventilation to the neonate, was recorded. If there was severe
respiratory depression, intramuscular naloxone was given to
restore ventilation, normal HR and skin color.
Maternal hypotension was defined as MAP< 60 mmHg or
decreased more than 30% as compared to its baseline value. It
was treated by increase in the rate of iv fluid infusion, followed
by iv ephedrine 10 mg boluses. Bradycardia was defined as
HR< 50 beats/min and treated with boluses of iv atropine
0.5 mg as required. Adverse effects (such as nausea and vom-
iting) for 24 h. after the operation were recorded.
3. Statistical analysis
For sample size calculation, mean arterial blood pressure
(MAP) was taken as a primary parameter of interest. It was
calculated that 21 subjects will be required per group in order
to detect a 20% difference in MAP; the a value was 0.05 and
the power (1  b) of the study was 0.80. We enrolled 50
patients (25/group) to allow for dropouts.
Data were analyzed using the SPSS statistics program (Ver-
sion 16, SPSS Inc, Chicago, IL, USA). According to the type
of data they were represented as mean and standard deviation
or frequencies and percentages. Comparisons of the two stud-
ied groups were performed using either Student t-test (for
parametric measures) or Mann-Whitney U test (for nonpara-
metric measures). In all tests results were considered statisti-
cally significant if p value was less than 0.5 (see Fig. 1).
4. Results
The results of the present study showed NO statistically signif-
icant difference between the two groups as regards the
patients’ characteristics (age, weight and height), average dose
of propofol required to maintain anesthesia, and the operative
data [duration of the surgery, time between induction and fetal
delivery (I-D interval), time between incision of the uterus and
delivery (U-D interval), and time between stop of the infusion
of the tested drugs and delivery] (Table 1).
As regards the mean arterial pressure (MAP) and heart rate
(HR), the present study showed that the MAP was statistically
significant lower in remifentanil group (R) compared to
dexmedetomidine group (D) when measured just after induc-
tion (TI), and it was also statistically significant lower com-
pared to the baseline reading (T0) in both groups. When
measured just after intubation (TT) and two minutes later
(TT2), and just after skin incision (TS) and two minutes later
(TS2), both MAP and HR showed slight increase compared
to the baseline reading (T0) but it was still lower in group
(R) compared to group (D). Later, after delivery of the baby
and at the end of the surgery, both MAP and HR showedNO statistically significant difference between the two studied
groups (Tables 2 and 3).
As regards the neonatal outcome and need for resuscita-
tion, the results of the present study showed that the Apgar
score was statistically significant lower in group (R) compared
to group (D), at both 1 min [6 (4–8) and 7 (5–9)], and 5 min
[8 (6–9) and 9 (7–9)], respectively. Consequently, the number
of neonates required resuscitative measures was clinically
higher in group (R) [40% required tactile stimulation, 12%
required bag-mask ventilation and 4% required tracheal intuba-
tion] compared to group (D) [24% required tactile stimulation,
4% required bag-mask ventilation and 0% required tracheal
intubation]. But, only the number of patients required tactile
stimulation was statistically significant (Table 4). None of
the neonates required naloxone to restore spontaneous ventila-
tion. There were NO maternal or neonatal complications
noticed in both groups.
5. Discussion
The present study showed a successful influence of both
remifentanil and dexmedetomidine for blunting of stress
response to tracheal intubation and skin incision in severely
preeclamptic parturients. However, remifentanil was margin-
ally more effective than dexmedetomidine, while dexmedeto-
midine showed a safer profile on the neonatal outcome.
Remifentanil-exposed neonates showed lower Apgar score at
the 1st. and 5th min which required more resuscitative mea-
sures (tactile stimulation), but neonates in both groups did
not require aggressive resuscitation measures in form of tra-
cheal intubation and subsequent mechanical ventilation.
The results of the present study were in agreement with the
study done by Yoo et al. [11] who examined different doses of
remifentanil to attenuate the pressor response to airway man-
agement in severely preeclamptic underwent C.S. under G.A.,
which showed that the effect of remifentanil was dose-
dependent with ED50 and ED95 of remifentanil were 0.59
and 1.34 lg/kg respectively.
Again, the results of the present study were in accordance
with those of the study done by Park et al. [12] who examined
two doses of remifentanil (0.5 and 1.0 lg/kg) on attenuating
the hemodynamic response to tracheal intubation in
preeclamptic patients underwent C.S. under G.A. which
showed that both doses successfully maintained the blood
pressure and heart within the baseline preoperative values after
intubation with the dose of 1.0 lg/kg was more effective.
But contrary to the present study, the results of Park et al.
[12] showed more lower Apgar score of the neonates at 1 and 5
min and more need for resuscitative measures (in the 1.0 lg/kg
remifentanil group, Apgar score was <7 in 58% of the neo-
nates and 25% of them required tracheal intubation). These
contradictions with the present study could be explained by
the longer U-D interval in their study (115 ± 61 sec) compared
to the present study (74.8 ± 17) at the same dose of
remifentanil.
Also, the results of the present study were in agreement
with those of the study done by Saleh ElSayed [27] which
showed that dexmedetomidine infusion of 0.4 lg/kg/h was
superior to fentanyl single dose of 1 lg/kg to suppress the
hemodynamic response to surgical stimulation in preeclamptic
parturients underwent C.S. under G.A. with the neonatal out-
Figure 1 Flow diagram of the studied patients enrolled in the study.
Table 1 Demographic data of the patients and operative data in the two studied groups.
Group (R) Group (D) P value
(n= 23) (n= 24)
Age (year) 30 ± 7 28 ± 9 0.178
Height (cm) 164 ± 4 163 ± 3 0.157
Weight (kg) 76 ± 8 77 ± 7 0.210
Duration of the surgery (min) 53 ± 9 51 ± 7 0.219
I-D interval (Induction to fetal delivery) (min) 10.9 ± 2 11.5 ± 2.6 0.159
U-D interval (Incision of the uterus to delivery) (sec) 74.8 ± 17 79.8 ± 14.9 0.136
D-D interval (Stop of the infusion to delivery) (min) 3.9 ± 1.9 3.6 ± 2.5 0.316
Dose of propofol required to maintain anesthesia (mg/kg/h) 5.8 ± 2.1 6.0 ± 1 0.073
No statistical difference between the two groups. Data represented as Mean ± SD.
Group (R) = Remifentanil group; Group (D) = Dexmedetomidine group.
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lower dose of dexmedetomidine infusion was used in the pre-
sent study (0.2 lg/kg/h), the use of loading dose (1 lg/kg),
together with the use of propofol total intravenous anesthesia
and MgSO4 and hydralazine (if needed), all these factors could
compensate for the difference between the two studies in the
maintenance dose of dexmedetomidine.
Contrary to the present study, the results of study done by
El-Tahan et al. [25], showed that dexmedetomidine was more
effective in doses 0.4 and 0.6 lg/kg/h rather than the 0.2 lg/kg/h dose in attenuating the pressor response to noxious stim-
uli. This contradiction as regards the proven effect of the low
dose 0.2 lg/kg, (used in the present study) may attribute to the
total intravenous anesthesia using propofol and also to the
preoperative use of MgSO4 and hydralazine to control the
blood pressure in the present study.
The results of the present study were matched with those of
the recent study done by Li et al. [28] who compared the effects
of both remifentanil and dexmedetomidine on both the par-
turient hemodynamics and the neonatal outcome in non-
Table 2 Mean arterial pressure (MAP) in the two studied groups.
Group (R) Group (D) P value
(n= 23) (n= 24)
T0 (after arterial cannula insertion) 111 ± 9 114 ± 8 0.1
TI (Just after induction of anesthesia) 84 ± 6 92 ± 7
* 0.000
TT1 (Just after intubation) 117 ± 9 123 ± 9
* 0.012
TT2 (2 min after intubation) 114 ± 7 119 ± 7
* 0.026
TS1 (Just after skin incision) 119 ± 7 127 ± 8
* 0.003
TS2 (2 min after skin incision) 113 ± 6 118 ± 7
* 0.028
TD (After delivery of the baby) 107 ± 5 110 ± 6 0.29
TE (At the end of the surgery) 102 ± 11 106 ± 10 0.059
Group (R) = Remifentanil group; Group (D) = Dexmedetomidine group.
* Statistically significant compared to group (R); (p< 0.05). Data represented as Mean ± SD.
Table 3 Heart rate (HR) in the two studied groups.
Group (R) Group (D) P value
(n= 23) (n= 24)
T0 (after arterial cannula insertion) 97 ± 5.1 96 ± 7.5 0.465
TI (Just after induction of anesthesia) 75 ± 3.9 79 ± 6.3
* 0.007
TT1 (Just after intubation) 101 ± 5.3 105 ± 8.2
* 0.033
TT2 (2 min after intubation) 99 ± 4.9 103 ± 7.8
* 0.031
TS1 (Just after skin incision) 104 ± 5.4 108 ± 6.7
* 0.037
TS2 (2 min after skin incision) 99 ± 3.5 103 ± 5.8
* 0.032
TD (After delivery of the baby) 91 ± 4.7 93 ± 7.2 0.156
TE (At the end of the surgery) 81 ± 4.2 83 ± 6.5 0.076
Group (R) = Remifentanil group; Group (D) = Dexmedetomidine group.
* Statistically significant compared to group (R); (p< 0.05). Data represented as Mean ± SD.
Table 4 Neonatal outcome and resuscitation measures in the two studied groups.
Group (R) Group (D) P value
(n= 23) (n= 24)
Apgar score (1 min) 6 (4–8) 7 (5–9)* 0.012
Apgar score (5 min) 8 (6–9) 9 (7–9)* 0.023
Resuscitation at 1 min:
Tactile stimulation (number) 10/25 (40%) 6/25 (24%)* 0.022
Bag–mask ventilation (number) 3/25 (12%) 1/25 (4%) 0.32
Tracheal intubation (number) 1/25 (4%) 0/25 (0%) 0.41
Group (R) = Remifentanil group; Group (D) = Dexmedetomidine group.
* Statistically significant compared to group (R); (p< 0.05). Data are represented as [median (range)] or numbers and percentages (%).
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remifentanil was more potent in suppressing the MAP
response to noxious stimuli, although dexmedetomidine
showed lower heart rate values intraoperatively, but the
neonatal outcome was in favor of dexmedetomidine as Apgar
score was higher at 1 and 5 min and less neonates required
bag-mask ventilation compared to remifentanil. These neona-
tal depressive effects of remifentanil may be attributed to their
use of higher loading dose (2 lg/kg) compared to the dose,
(1 lg/kg or less), used in the present study and studies done
by other investigators [11,12,31].
There were some limitations of our study. One of them was
the lack of resources to compare plasma levels of the studied
drugs in both parturient and neonate circulations. Our studywas not designed to estimate the preemptive analgesic effect
of studied drugs on postoperative analgesia after CS, hopping
to do so in further studies. Also, our study excluded cases with
fetal distress, one of the main indications for CS under GA.
We excluded them from the current study due to the lack of
proof about their effect on neonatal outcome.
6. Conclusion
Both remifentanil and dexmedetomidine were effective on
blunting the pressor response to noxious stimuli in severely
preeclamptic parturients. While remifentanil was marginally
more effective in suppressing the pressor response, dexmedeto-
midine was safer for the neonates.
494 A.A. Badawy, A.M. MokhtarConflict of interest
We have no conflict of interest to declare.
References
[1] Prys-Roberts C, Greene LT, Meloche R, Foe¨x P. Studies of
anaesthesia in relation to hypertension. II. Haemodynamic
consequences of induction and endotracheal intubation. Br J
Anaesth 1971;43:531–47.
[2] Connell H, Dalgleish JG, Downing JW. General anaesthesia in
mothers with severe pre-eclampsia/eclampsia. Br J Anaesth
1987;59:1375–80.
[3] Huang C-J, Fan Y-C, Tsai P-S. Differential impacts of modes of
anaesthesia on the risk of stroke among preeclamptic women
who undergo Caesarean delivery: a population-based study. Br J
Anaesth 2010;105:818–26.
[4] Lawes EG, Downing JW, Duncan PW, Bland B, Lavies N, Gane
GA. Fentanyl-droperidol supplementation of rapid sequence
induction in the presence of severe pregnancy-induced and
pregnancy-aggravated hypertension. Br J Anaesth
1987;59:1381–91.
[5] Loughran PG, Moore J, Dundee JW. Maternal stress response
associated with caesarean delivery under general and epidural
anaesthesia. Br J Obstet Gynaecol 1986;93:943–9.
[6] Gin T, O’Meara ME, Kan AF, Leung RK, Tan P, Yau G.
Plasma catecholamines and neonatal condition after induction
of anaesthesia with propofol or thiopentone at caesarean
section. Br J Anaesth 1993;70:311–6.
[7] Glass PS, Hardman D, Kamiyama Y, Quill TJ, Marton G,
Donn KH, et al. Preliminary pharmacokinetics and
pharmacodynamics of an ultra-short-acting opioid:
remifentanil (GI87084B). Anesth Analg 1993;77:1031–40.
[8] Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ,
Shiraishi M, et al. Measured context-sensitive half-times of
remifentanil and alfentanil. Anesthesiology 1995;83:968–75.
[9] Ngan Kee WD, Khaw KS, Ma KC, Wong ASY, Lee BB, Ng
FF. Maternal and neonatal effects of remifentanil at induction
of general anesthesia for cesarean delivery: a randomized,
double-blind, controlled trial. Anesthesiology 2006;104:14–20.
[10] Draisci G, Valente A, Suppa E, Frassanito L, Pinto R, Meo F,
et al. Remifentanil for cesarean section under general anesthesia:
effects on maternal stress hormone secretion and neonatal well-
being: a randomized trial. Int J Obstet Anesth 2008;17:130–6.
[11] Yoo KY, Kang DH, Jeong H, Jeong CW, Choi YY, Lee J. A
dose-response study of remifentanil for attenuation of the
hypertensive response to laryngoscopy and tracheal intubation
in severely preeclamptic women undergoing caesarean delivery
under general anaesthesia. Int J Obstet Anesth 2013;22:10–8.
[12] Park BY, Jeong CW, Jang EA, Kim SJ, Jeong ST, Shin MH,
et al. Dose-related attenuation of cardiovascular responses to
tracheal intubation by intravenous remifentanil bolus in severe
pre-eclamptic patients undergoing Caesarean delivery. Br J
Anaesth 2011;106:82–7.
[13] Heesen M, Klo¨hr S, Hofmann T, Rossaint R, Devroe S, Straube
S, et al. Maternal and foetal effects of remifentanil for general
anaesthesia in parturients undergoing caesarean section: a
systematic review and meta-analysis. Acta Anaesthesiol Scand
2013;57:29–36.
[14] Martin JN, Thigpen BD, Moore RC, Rose CH, Cushman J,
May W. Stroke and severe preeclampsia and eclampsia: a
paradigm shift focusing on systolic blood pressure. Obstet
Gynecol 2005;105:246–54.
[15] Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative,
amnestic, and analgesic properties of small-dose
dexmedetomidine infusions. Anesth Analg 2000;90:699–705.[16] Kamibayashi T, Maze M. Clinical uses of a2-adrenergic
agonists. Anesthesiology 2000;93:1345–9.
[17] Hanci V, Erdog˘an G, Okyay RD, Yurtlu BS, Ayog˘lu H,
Baydilek Y, et al. Effects of fentanyl-lidocaine-propofol and
dexmedetomidine-lidocaine-propofol on tracheal intubation
without use of muscle relaxants. Kaohsiung J Med Sci
2010;26:244–50.
[18] Basar H, Akpinar S, Doganci N, Buyukkocak U, Kaymak C,
Sert O, et al. The effects of preanesthetic, single-dose
dexmedetomidine on induction, hemodynamic, and
cardiovascular parameters. J Clin Anesth 2008;20:431–6.
[19] Kunisawa T, Nagata O, Nagashima M, Mitamura S, Ueno M,
Suzuki A, et al. Dexmedetomidine suppresses the decrease in
blood pressure during anesthetic induction and blunts the
cardiovascular response to tracheal intubation. J Clin Anesth
2009;21:194–9.
[20] Keniya VM, Ladi S, Naphade R. Dexmedetomidine attenuates
sympathoadrenal response to tracheal intubation and reduces
perioperative anaesthetic requirement. Indian J Anaesth
2011;55:352–7.
[21] Yildiz M, Tavlan A, Tuncer S, Reisli R, Yosunkaya A,
Otelcioglu S. Effect of dexmedetomidine on haemodynamic
responses to laryngoscopy and intubation: perioperative
haemodynamics and anaesthetic requirements. Drugs R D
2006;7:43–52.
[22] Ma´lek J, Marecek F, Hess L, Kurzova´ A, Ocadlı´k M, Votava
M. A combination of dexmedetomidine with ketamine and
opioids results in significant inhibition of hemodynamic changes
associated with laparoscopic cholecystectomy and in
prolongation of postoperative analgesia. Rozhl v Chir
Meˇsı´cˇnı´k Cˇeskoslovenske´ Chir Spolecˇnosti 2010;89:275–81.
[23] Palanisamy A, Klickovich RJ, Ramsay M, Ouyang DW, Tsen
LC. Intravenous dexmedetomidine as an adjunct for labor
analgesia and cesarean delivery anesthesia in a parturient with a
tethered spinal cord. Int J Obstet Anesth 2009;18:258–61.
[24] Abu-Halaweh SA, Al Oweidi A-KS, Abu-Malooh H, Zabalawi
M, Alkazaleh F, Abu-Ali H, et al. Intravenous
dexmedetomidine infusion for labour analgesia in patient with
preeclampsia. Eur J Anaesthesiol 2009;26:86–7.
[25] El-Tahan MR, Mowafi HA, Al Sheikh IH, Khidr AM, Al-
Juhaiman RA. Efficacy of dexmedetomidine in suppressing
cardiovascular and hormonal responses to general anaesthesia
for caesarean delivery: a dose-response study. Int J Obstet
Anesth 2012;21:222–9.
[26] El-Sakka A, Helmy N, Helmy J, Rafaat H. The hemodynamic
and analgesic profile of dexmedetomidine against fentanyl in
preeclamptic parturients undergoing Cesarean section under
general anesthesia. Ain-Shams J Anaesthesiol 2015;8:183.
[27] Saleh ElSayed RS. Study of the effect of dexmedetomidine in
reducing hemodynamic responses to general anesthesia for
elective cesarean section in patients with preeclampsia. J
Anesth Clin Res 2015;6.
[28] Li C, Li Y, Wang K, Kong X. Comparative evaluation of
remifentanil and dexmedetomidine in general anesthesia for
cesarean delivery. Med Sci Monit 2015;21:3806–13.
[29] Gogarten W. Preeclampsia and anaesthesia. Curr Opin
Anaesthesiol 2009;22:347–51.
[30] Lambert G, Brichant JF, Hartstein G, Bonhomme V. PYD.
Preeclampsia: an update. Belgica. Acta Anaesthesiol
2014;65:137–49.
[31] Pournajafian A, Rokhtabnak F, Kholdbarin A, Ghodrati M,
Ghavam S. Comparison of remifentanil and fentanyl regarding
hemodynamic changes due to endotracheal intubation in
preeclamptic parturient candidate for cesarean delivery.
Anesthesiol Pain Med 2012;2:90–3.
